GSK Insider Trading

Insider Ownership Percentage: 0.72%
Insider Buying (Last 12 Months): £125,044.63
Insider Selling (Last 12 Months): £3,043,420.87

GSK Insider Trading History Chart

This chart shows the insider buying and selling history at GSK by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

GSK Share Price & Price History

Current Price: GBX 1,420
Price Change: Price Decrease of -0.6 (-0.04%)
As of 03/30/2023 10:41 PM ET

This chart shows the closing price history over time for GSK up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

GSK Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/20/2023Jonathan SymondsInsiderBuy2,100GBX 1,399£29,379
2/14/2023Emma WalmsleyInsiderSell28,576GBX 1,487£424,925.12
2/9/2023Emma WalmsleyInsiderBuy8GBX 1,514£121.12
1/11/2023Emma WalmsleyInsiderBuy9GBX 1,417£127.53
12/22/2022Urs RohnerInsiderBuy798GBX 1,453£11,594.94
12/20/2022Jonathan SymondsInsiderBuy2,100GBX 1,417£29,757
11/9/2022Emma WalmsleyInsiderBuy8GBX 1,396£111.68
9/29/2022Jonathan SymondsInsiderBuy3,220GBX 1,324£42,632.80
9/9/2022Emma WalmsleyInsiderBuy9GBX 1,362£122.58
8/9/2022Emma WalmsleyInsiderBuy8GBX 1,641£131.28
7/27/2022Emma WalmsleyInsiderSell148,525GBX 1,763£2,618,495.75
7/4/2022Emma WalmsleyInsiderBuy7GBX 1,799£125.93
6/23/2022Manvinder Singh BangaInsiderBuy647GBX 1,691£10,940.77
3/23/2022Charles BancroftInsiderBuy2,790GBX 2,114£58,980.60
2/14/2022Emma WalmsleyInsiderSell34,031GBX 1,610£547,899.10
2/9/2022Emma WalmsleyInsiderBuy8GBX 1,627£130.16
1/12/2022Emma WalmsleyInsiderBuy7GBX 1,638£114.66
11/22/2021Hal BarronInsiderBuy2,422GBX 2,065£50,014.30
10/11/2021Emma WalmsleyInsiderBuy9GBX 1,397£125.73
8/10/2021Emma WalmsleyInsiderBuy8GBX 1,447£115.76
7/9/2021Emma WalmsleyInsiderBuy9GBX 1,430£128.70
5/12/2021Emma WalmsleyInsiderBuy10GBX 1,341£134.10
4/28/2021Urs RohnerInsiderBuy629GBX 1,340£8,428.60
4/13/2021Emma WalmsleyInsiderBuy9GBX 1,291£116.19
3/1/2021Emma WalmsleyInsiderSell32,346GBX 1,211£391,710.06
2/9/2021Emma WalmsleyInsiderBuy10GBX 1,272£127.20
2/3/2021Urs RohnerInsiderBuy619GBX 1,361£8,424.59
1/12/2021Emma WalmsleyInsiderBuy9GBX 1,384£124.56
12/30/2020Manvinder Singh BangaInsiderBuy36,600GBX 1,376£503,616
12/9/2020Emma WalmsleyInsiderBuy9GBX 1,403£126.27
11/10/2020Emma WalmsleyInsiderBuy9GBX 1,462£131.58
10/28/2020Jonathan SymondsInsiderBuy3,240,741GBX 1,350£43,750,003.50
10/9/2020Emma WalmsleyInsiderBuy8GBX 1,440£115.20
9/10/2020Emma WalmsleyInsiderBuy8GBX 1,520£121.60
8/11/2020Emma WalmsleyInsiderBuy8GBX 1,598£127.84
7/9/2020Emma WalmsleyInsiderBuy8GBX 1,610£128.80
5/12/2020Emma WalmsleyInsiderBuy7GBX 1,693£118.51
4/9/2020Emma WalmsleyInsiderBuy28GBX 1,536£430.08
See Full Table

SEC Filings (Institutional Ownership Changes) for GSK (LON:GSK)

39.08% of GSK stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

GSK logo
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Wave Life Sciences Ltd.; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Read More on GSK

Today's Range

Now: GBX 1,420
Low: 1,412.60
High: 1,421.60

50 Day Range

MA: GBX 1,433.76
Low: 1,376.60
High: 1,502.60

52 Week Range

Now: GBX 1,420
Low: 1,280.92
High: 2,280.50


2,482,277 shs

Average Volume

8,249,175 shs

Market Capitalization

£58.08 billion

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of GSK?

GSK's top insider shareholders include:
  1. Charles Bancroft (Insider)
  2. Emma Walmsley (Insider)
  3. Hal Barron (Insider)
  4. Jonathan Symonds (Insider)
  5. Manvinder Singh Banga (Insider)
  6. Urs Rohner (Insider)
Learn More about top insider investors at GSK.